Search Thermo Fisher Scientific
Clinical Research Applications
LCMS targeted quantitation clinical research workflow solutions
Together, we are helping clinical researchers understand how they can analyze complex biological samples more rapidly, robustly, and with greater confidence in the results they provide. MS is empowering medical scientists and clinicians with more cost effective and confident results to unlock the answers physicians need. Always remember, what you do in clinical research changes the world one life at a time. Be someone’s hero.
Quick links
Be someone’s hero when time is precious and obtain reliability and sensitivity with confidence
Click image to enlarge
Robust and consistent performance under challenging conditions
Click image to enlarge
Excellent precision for the most challenging quantitative assays
Click image to enlarge
Achieve sensitivity requirements for challenging analytes of interest
For Research Use Only. Not for use in diagnostic procedures.
Emergence of Clinical Proteomics: Identifying and developing actionable protein biomarkers for use in clinical research
Continuing education credits: P.A.C.E. CE | Florida CE
This webinar will cover how quantitative proteomic markers are introduced into our CAP-CLIA laboratory via an assay development pipeline. Starting from a targeted-discovery initiative, and progressing to the analytical validation of our multiplexed SRM methods, we review the metrics used to validate our assays.
This webinar also discusses the impact that these developed markers have on clinical research, including the retrospective analyses of HER2 proteomic expression in adjuvant and metastatic breast cancer and in advanced gastric cancer.
Metabolomics research at the University of Liverpool's Institute of Integrative Biology seeks to answer multiple questions from increasing yields in crops, resistance to diseases, anti-microbial resistance and how drugs enter cells. Using a range of analytical techniques, including mass spectrometry, is critical to enable this understanding. Find out how it all comes together.
Immunoassay has been the gold standard biomolecule assay for the past fifty years, but those fifty years have highlighted both the benefits and limitations of the immunoassay. LC/MS represents a complementary and potentially future replacement of the immunoassay by offering greater specificity, speed, analyte range, throughput, and multiplexing capabilities coupled with a lower cost per sample and reduced sample volumes.
In this e-book we examine the trends and pain points in clinical research, and show how MS is helping clinical laboratories around the world find the answers to complex healthcare questions.
LC-MS webinar series
Expand your application knowledge
Our LC-MS on-demand webinar series expands your application knowledge for pharma, biopharma, environmental, omics, food, forensics and clinical research and more. Learn how the latest high-performance mass spectrometry solutions can enable your laboratory to solve your most pressing analytical challenges, regardless of sample type.
Support